NCT06700915View on ClinicalTrials.gov

A Clinical Trial to Assess the Efficacy and Tolerance of a Berberine-based Nutraceutical Formula to Aid Blood Sugar Regulation and Metabolism

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 3, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2025

Conditions
Metabolism DisorderNutraceutical
Interventions
DIETARY_SUPPLEMENT

Diaberine

Participants will take one capsule three times daily, 15 minutes prior to meals, over a 24-week period.

DIETARY_SUPPLEMENT

Placebo Capsule

Participants will take one capsule three times daily, 15 minutes prior to meals, over a 24-week period.

Trial Locations (1)

90404

RECRUITING

Citruslabs, Santa Monica

Sponsors

Collaborators (1)

Citruslabs
All Listed Sponsors
collaborator

Citruslabs

INDUSTRY

lead

Ultimate International, Inc.

INDUSTRY

NCT06700915 - A Clinical Trial to Assess the Efficacy and Tolerance of a Berberine-based Nutraceutical Formula to Aid Blood Sugar Regulation and Metabolism | Biotech Hunter | Biotech Hunter